Published in Antimicrob Agents Chemother on April 01, 1982
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus. Infection (1985) 1.02
Interaction of cefotaxime and aminoglycosides against enterococci in vitro. Antimicrob Agents Chemother (1983) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
In vitro activity of LY127935. Antimicrob Agents Chemother (1979) 7.01
In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic. Antimicrob Agents Chemother (1980) 1.46
Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22
Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin. J Antibiot (Tokyo) (1979) 1.11
Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol (1998) 3.51
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Comparison of rapid identification assays for Staphylococcus aureus. J Clin Microbiol (1984) 2.62
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol (1994) 2.29
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med (1983) 2.17
Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol (1983) 2.11
Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations. Antimicrob Agents Chemother (1985) 2.02
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother (1990) 1.96
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Clin Infect Dis (1998) 1.80
Defense factors of vaginal lactobacilli. Am J Obstet Gynecol (2001) 1.68
Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis (1987) 1.53
Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (1997) 1.51
Brain serotonin synthesis rates in rhesus monkeys determined by [11C]alpha-methyl-L-tryptophan and positron emission tomography compared to CSF 5-hydroxyindole-3-acetic acid concentrations. Neuropsychopharmacology (1998) 1.48
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species. Antimicrob Agents Chemother (1984) 1.40
Persistent low cerebral blood flow velocity following profound hypothermic circulatory arrest in infants. Can J Anaesth (1995) 1.40
Shigellosis in day-care centres. Lancet (1975) 1.38
Reduced central serotonin transporters in alcoholism. Am J Psychiatry (1998) 1.31
Prenatal detection of heart defects in a non-selected population of 30,149 fetuses--detection rates and outcome. Ultrasound Obstet Gynecol (2006) 1.31
Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol (1983) 1.29
Equating the MOS SF36 and the LSU HSI Physical Functioning Scales. J Outcome Meas (1997) 1.27
Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis (1988) 1.26
Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg (1998) 1.24
Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin Infect Dis (2001) 1.24
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension. Am J Cardiol (1999) 1.23
Cefamandole therapy in anaerobic infections. Antimicrob Agents Chemother (1979) 1.22
Single-dose cefaclor therapy of urinary tract infection. Evaluation of antibody-coated bacteria test and C-reactive protein assay as predictors of cure. Am J Med (1981) 1.20
Identification of the 9G4 idiotope in systemic lupus erythematosus. Br J Rheumatol (1993) 1.16
Typhoid fever in pregnancy. A case report. J Reprod Med (1990) 1.16
In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents. J Antimicrob Chemother (1990) 1.15
Decreased corpus callosum size among alcoholic women. Arch Neurol (1996) 1.15
Unusual manifestations of invasive pneumococcal infection. Am J Med (1999) 1.14
Long-term surveillance for adverse effects of antihypertensive drugs. JAMA (1985) 1.13
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. J Clin Microbiol (1987) 1.13
Skin and soft tissue infections in critical care. Crit Care Clin (1998) 1.13
Study of teaching residents how to teach. J Med Educ (1988) 1.13
Chronic postrheumatic-fever (Jaccoud's) arthritis. Case report with the rheumatoid factor and a family history of rheumatoid arthritis. Arch Intern Med (1967) 1.12
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother (1990) 1.10
Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol (1996) 1.09
Evaluation of a teaching skills improvement programme for residents. Med Educ (1988) 1.09
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis. Sex Transm Dis (1986) 1.07
Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis (2000) 1.07
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis (1990) 1.06
Poststreptococcal glomerulonephritis: how important is it as a cause of chronic renal diseases. Transplant Proc (1987) 1.06
The microbiology of post-cesarean wound morbidity. Obstet Gynecol (1993) 1.05
Clinical and hemodynamic criteria for use of the intra-aortic balloon pump in patients requiring cardiac surgery. J Thorac Cardiovasc Surg (1976) 1.04
The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol (1999) 1.04
Retrospective evaluation of the isolation and identification of herpes simplex virus with Cultureset and human fibroblasts. J Clin Microbiol (1985) 1.04
Susceptibility of female pelvic pathogens to oral antibiotic agents in patients who develop postpartum endometritis. Am J Obstet Gynecol (1991) 1.02
In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline. Tubercle (1978) 1.02
Role of imipenem/cilastatin in the treatment of soft tissue infections. Am J Med (1985) 1.01
Elevated mannose levels detected by gas-liquid chromatography in hydrolysates of serum from rats and humans with candidiasis. J Clin Microbiol (1982) 1.01
Human monoclonal antibodies to phenolic glycolipid-I derived from patients with leprosy, and production of specific anti-idiotypes. Immunology (1988) 1.01
NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW. Int J Probiotics Prebiotics (2008) 1.00
Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost (1994) 1.00
Cefamandole and cefoxitin. Ann Intern Med (1985) 1.00
Ubiquinone biosynthesis in Saccharomyces cerevisiae. Isolation and sequence of COQ3, the 3,4-dihydroxy-5-hexaprenylbenzoate methyltransferase gene. J Biol Chem (1991) 0.99
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group. Obstet Gynecol (1994) 0.99
Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol (1994) 0.99
Colon cancer in blacks: a disease with a worsening prognosis. J Natl Med Assoc (1991) 0.99
Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. J Reprod Med (1995) 0.98
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother (1986) 0.98
Apollo 11 Laser Ranging Retro-Reflector: Initial Measurements from the McDonald Observatory. Science (1970) 0.98
Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis (1998) 0.98
Tuberculin, tine test in infection and disease. South Med J (1967) 0.98
Pelvic inflammatory disease. Key treatment issues and options. JAMA (1991) 0.98
Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. South Med J (1993) 0.98
Short-course parenteral antibiotic therapy for pyelonephritis in pregnancy. South Med J (1984) 0.97
Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol (2005) 0.97
39Ar detection at the 10(-16) isotopic abundance level with atom trap trace analysis. Phys Rev Lett (2011) 0.97
Analysis of autoantibody reactivity and common idiotype PR4 expression of myeloma proteins. J Autoimmun (1989) 0.97
Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother (1977) 0.97
Group B beta-hemolytic streptococci and puerperal infections. Am J Obstet Gynecol (1981) 0.97
Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus. Infect Dis Obstet Gynecol (2007) 0.96
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria. Antimicrob Agents Chemother (1982) 0.96
MR of the cerebral operculum: topographic identification and measurement of interopercular distances in healthy infants and children. AJNR Am J Neuroradiol (1995) 0.95
Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart (2001) 0.95
Age-related differences in the frequency of personality disorders among inpatient veterans. Int J Geriatr Psychiatry (2000) 0.95
Pyelonephritis and sepsis due to Staphylococcus saprophyticus. J Infect Dis (1987) 0.95
Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. J Hepatol (2001) 0.94
Long-term evaluation of training residents in clinical teaching skills. J Med Educ (1986) 0.94
Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect Dis Obstet Gynecol (2001) 0.94
Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories. J Autoimmun (1990) 0.94
Evaluation of an HIV prevention intervention for African Americans and Hispanics: findings from the VOICES/VOCES Community-based Organization Behavioral Outcomes Project. AIDS Behav (2011) 0.94
Vibrio vulnificus infection. Case report and update since 1970. J Am Acad Dermatol (1983) 0.94